Modeling sporadic ALS in iPSC-derived motor neurons identifies a potential therapeutic agent

Koki Fujimori, Mitsuru Ishikawa, Asako Otomo, Naoki Atsuta, Ryoichi Nakamura, Tetsuya Akiyama, Shinji Hadano, Masashi Aoki, Hideyuki Saya, Gen Sobue, Hideyuki Okano

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Amyotrophic lateral sclerosis (ALS) is a heterogeneous motor neuron disease for which no effective treatment is available, despite decades of research into SOD1-mutant familial ALS (FALS). The majority of ALS patients have no familial history, making the modeling of sporadic ALS (SALS) essential to the development of ALS therapeutics. However, as mutations underlying ALS pathogenesis have not yet been identified, it remains difficult to establish useful models of SALS. Using induced pluripotent stem cell (iPSC) technology to generate stem and differentiated cells retaining the patients’ full genetic information, we have established a large number of in vitro cellular models of SALS. These models showed phenotypic differences in their pattern of neuronal degeneration, types of abnormal protein aggregates, cell death mechanisms, and onset and progression of these phenotypes in vitro among cases. We therefore developed a system for case clustering capable of subdividing these heterogeneous SALS models by their in vitro characteristics. We further evaluated multiple-phenotype rescue of these subclassified SALS models using agents selected from non-SOD1 FALS models, and identified ropinirole as a potential therapeutic candidate. Integration of the datasets acquired in this study permitted the visualization of molecular pathologies shared across a wide range of SALS models.

Original languageEnglish
JournalNature Medicine
DOIs
Publication statusAccepted/In press - 2018 Jan 1

Fingerprint

Induced Pluripotent Stem Cells
Amyotrophic Lateral Sclerosis
Motor Neurons
Stem cells
Neurons
Phenotype
Motor Neuron Disease
Molecular Pathology
Therapeutics
Cluster Analysis
Cell Death
Stem Cells
History
Technology
Mutation
Pathology
Cell death
Amyotrophic lateral sclerosis 1
Research
Visualization

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Modeling sporadic ALS in iPSC-derived motor neurons identifies a potential therapeutic agent. / Fujimori, Koki; Ishikawa, Mitsuru; Otomo, Asako; Atsuta, Naoki; Nakamura, Ryoichi; Akiyama, Tetsuya; Hadano, Shinji; Aoki, Masashi; Saya, Hideyuki; Sobue, Gen; Okano, Hideyuki.

In: Nature Medicine, 01.01.2018.

Research output: Contribution to journalArticle

Fujimori, K, Ishikawa, M, Otomo, A, Atsuta, N, Nakamura, R, Akiyama, T, Hadano, S, Aoki, M, Saya, H, Sobue, G & Okano, H 2018, 'Modeling sporadic ALS in iPSC-derived motor neurons identifies a potential therapeutic agent', Nature Medicine. https://doi.org/10.1038/s41591-018-0140-5
Fujimori, Koki ; Ishikawa, Mitsuru ; Otomo, Asako ; Atsuta, Naoki ; Nakamura, Ryoichi ; Akiyama, Tetsuya ; Hadano, Shinji ; Aoki, Masashi ; Saya, Hideyuki ; Sobue, Gen ; Okano, Hideyuki. / Modeling sporadic ALS in iPSC-derived motor neurons identifies a potential therapeutic agent. In: Nature Medicine. 2018.
@article{8240b22541724ef6b4e467cff2da7bf3,
title = "Modeling sporadic ALS in iPSC-derived motor neurons identifies a potential therapeutic agent",
abstract = "Amyotrophic lateral sclerosis (ALS) is a heterogeneous motor neuron disease for which no effective treatment is available, despite decades of research into SOD1-mutant familial ALS (FALS). The majority of ALS patients have no familial history, making the modeling of sporadic ALS (SALS) essential to the development of ALS therapeutics. However, as mutations underlying ALS pathogenesis have not yet been identified, it remains difficult to establish useful models of SALS. Using induced pluripotent stem cell (iPSC) technology to generate stem and differentiated cells retaining the patients’ full genetic information, we have established a large number of in vitro cellular models of SALS. These models showed phenotypic differences in their pattern of neuronal degeneration, types of abnormal protein aggregates, cell death mechanisms, and onset and progression of these phenotypes in vitro among cases. We therefore developed a system for case clustering capable of subdividing these heterogeneous SALS models by their in vitro characteristics. We further evaluated multiple-phenotype rescue of these subclassified SALS models using agents selected from non-SOD1 FALS models, and identified ropinirole as a potential therapeutic candidate. Integration of the datasets acquired in this study permitted the visualization of molecular pathologies shared across a wide range of SALS models.",
author = "Koki Fujimori and Mitsuru Ishikawa and Asako Otomo and Naoki Atsuta and Ryoichi Nakamura and Tetsuya Akiyama and Shinji Hadano and Masashi Aoki and Hideyuki Saya and Gen Sobue and Hideyuki Okano",
year = "2018",
month = "1",
day = "1",
doi = "10.1038/s41591-018-0140-5",
language = "English",
journal = "Nature Medicine",
issn = "1078-8956",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Modeling sporadic ALS in iPSC-derived motor neurons identifies a potential therapeutic agent

AU - Fujimori, Koki

AU - Ishikawa, Mitsuru

AU - Otomo, Asako

AU - Atsuta, Naoki

AU - Nakamura, Ryoichi

AU - Akiyama, Tetsuya

AU - Hadano, Shinji

AU - Aoki, Masashi

AU - Saya, Hideyuki

AU - Sobue, Gen

AU - Okano, Hideyuki

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Amyotrophic lateral sclerosis (ALS) is a heterogeneous motor neuron disease for which no effective treatment is available, despite decades of research into SOD1-mutant familial ALS (FALS). The majority of ALS patients have no familial history, making the modeling of sporadic ALS (SALS) essential to the development of ALS therapeutics. However, as mutations underlying ALS pathogenesis have not yet been identified, it remains difficult to establish useful models of SALS. Using induced pluripotent stem cell (iPSC) technology to generate stem and differentiated cells retaining the patients’ full genetic information, we have established a large number of in vitro cellular models of SALS. These models showed phenotypic differences in their pattern of neuronal degeneration, types of abnormal protein aggregates, cell death mechanisms, and onset and progression of these phenotypes in vitro among cases. We therefore developed a system for case clustering capable of subdividing these heterogeneous SALS models by their in vitro characteristics. We further evaluated multiple-phenotype rescue of these subclassified SALS models using agents selected from non-SOD1 FALS models, and identified ropinirole as a potential therapeutic candidate. Integration of the datasets acquired in this study permitted the visualization of molecular pathologies shared across a wide range of SALS models.

AB - Amyotrophic lateral sclerosis (ALS) is a heterogeneous motor neuron disease for which no effective treatment is available, despite decades of research into SOD1-mutant familial ALS (FALS). The majority of ALS patients have no familial history, making the modeling of sporadic ALS (SALS) essential to the development of ALS therapeutics. However, as mutations underlying ALS pathogenesis have not yet been identified, it remains difficult to establish useful models of SALS. Using induced pluripotent stem cell (iPSC) technology to generate stem and differentiated cells retaining the patients’ full genetic information, we have established a large number of in vitro cellular models of SALS. These models showed phenotypic differences in their pattern of neuronal degeneration, types of abnormal protein aggregates, cell death mechanisms, and onset and progression of these phenotypes in vitro among cases. We therefore developed a system for case clustering capable of subdividing these heterogeneous SALS models by their in vitro characteristics. We further evaluated multiple-phenotype rescue of these subclassified SALS models using agents selected from non-SOD1 FALS models, and identified ropinirole as a potential therapeutic candidate. Integration of the datasets acquired in this study permitted the visualization of molecular pathologies shared across a wide range of SALS models.

UR - http://www.scopus.com/inward/record.url?scp=85052322697&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85052322697&partnerID=8YFLogxK

U2 - 10.1038/s41591-018-0140-5

DO - 10.1038/s41591-018-0140-5

M3 - Article

JO - Nature Medicine

JF - Nature Medicine

SN - 1078-8956

ER -